/Companies

Acta Pharmaceuticals

Boston, US · Founded 2022 · Delaware corporation

Find your way into Acta Pharmaceuticals

Sign up to see every warm intro you have to Acta Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Acta Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

GA
George AlexNamed on SEC filing
TP
Thierry PorteNamed on SEC filing
RT
Rudolph TanziNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$13.4M disclosed across 1 round · 2023

▶$13.4MraisedApr 2024 · 29 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • George AlexExecutive Officer, Director
  • Thierry PorteDirector
  • Rudolph TanziDirector
Offering amount
$17.5M
Amount sold
$13.4M
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Acta Pharmaceuticals raised?
Acta Pharmaceuticals has disclosed $13.4M raised across 1 round.
Where is Acta Pharmaceuticals headquartered?
Acta Pharmaceuticals is headquartered in Boston, US.